3LP.F · Columbia Care Inc

-

Please sign in to comment on 3LP.F

1 Comment

Admin

4 years, 1 month ago

Columbia Care Inc is currently in a long term downtrend where the price is trading 11.0% below its 200 day moving average.

From a valuation standpoint, the stock is 99.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 8.4.

Columbia Care Inc's total revenue rose by 228.3% to $76M since the same quarter in the previous year.

Its net income has dropped by 115.6% to $-56M since the same quarter in the previous year.

Finally, its free cash flow grew by 68.0% to $-10M since the same quarter in the previous year.

Based on the above factors, Columbia Care Inc gets an overall score of 3/5.

Exchange	F
CurrencyCode	EUR
ISIN	CA1973091079
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic

Market Cap	502M
PE Ratio	None
Target Price	2.35
Dividend Yield	0.0%
Beta	1.76

ABOUT

Columbia Care Inc

Columbia Care Inc. engages in cultivation, manufacture, and provision of cannabis products and related services in the United States and internationally. The company offers spanning flower, edibles, oils, and tablets under the Seed & Strain, Triple Seven, Hedy, gLeaf, Classix, Press, and Amber brand names. It holds licenses in 17 jurisdictions in the United States. The company was founded in 2012 and is headquartered in New York, New York.

3LP.F · Columbia Care Inc

-

Columbia Care Inc

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Columbia Care Inc using a moving average strategy